Author | Axel Hoos, MD, PhD | OncLive

Author | Axel Hoos, MD, PhD

Articles

Dr. Hoos Discusses the Next Steps for Ipilimumab

August 09, 2011

Video

Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses the Next Steps for Ipilimumab

Dr. Hoos Discusses Patients Eligible to Receive Ipilimumab

August 03, 2011

Video

Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses Which Patients are Eligible to Receive Ipilimumab

Dr. Hoos on the Ipilimumab Plus Dacarbazine Trial

July 29, 2011

Video

Dr. Axel Hoos medical lead at bristol-myers squibb on the Ipilimumab Plus Dacarbazine Combination Trial

Dr. Hoos on Why Melanoma is Amenable to Immunotherapy

July 26, 2011

Video

Dr. Axel Hoos medical lead at Bristol-Myers Squibb on Why Melanoma is Amenable to Immunotherapy

x